Thomas David Hull III Sells 2,000 Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III sold 2,000 shares of the business’s stock in a transaction dated Thursday, December 26th. The stock was sold at an average price of $63.01, for a total value of $126,020.00. Following the transaction, the chief executive officer now directly owns 42,497 shares of the company’s stock, valued at approximately $2,677,735.97. This represents a 4.49 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Kewaunee Scientific Stock Up 0.4 %

KEQU stock traded up $0.23 during trading on Friday, hitting $63.85. 28,625 shares of the company’s stock were exchanged, compared to its average volume of 17,455. The business has a 50-day moving average price of $41.99 and a two-hundred day moving average price of $43.12. The company has a current ratio of 2.53, a quick ratio of 2.00 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $183.25 million, a price-to-earnings ratio of 10.12 and a beta of 0.80. Kewaunee Scientific Co. has a 52-week low of $27.00 and a 52-week high of $66.15.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. JPMorgan Chase & Co. raised its stake in Kewaunee Scientific by 18,000.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after acquiring an additional 900 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Kewaunee Scientific by 8.9% in the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock valued at $792,000 after purchasing an additional 1,941 shares during the last quarter. Ritholtz Wealth Management boosted its position in shares of Kewaunee Scientific by 24.6% in the 3rd quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock valued at $363,000 after purchasing an additional 2,156 shares during the period. Barclays PLC purchased a new position in Kewaunee Scientific during the 3rd quarter worth approximately $121,000. Finally, Heron Bay Capital Management acquired a new position in Kewaunee Scientific during the second quarter worth approximately $252,000. Institutional investors and hedge funds own 32.69% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com raised Kewaunee Scientific from a “hold” rating to a “buy” rating in a report on Wednesday, December 18th.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.